Durstenfeld MS, Levkova-Clark M, Ms DL, Schaffer V, et al. Rationale, design, and baseline characteristics of the Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection: EPIC-HIV Randomized Clinical Trial. Am Heart J 2026 Feb 28:107400. doi: 10.1016/j.ahj.2026.107400.
PMID: 41771366